FIGURE
Figure 2—figure supplement 3.
- ID
- ZDB-FIG-210218-34
- Publication
- Fazio et al., 2021 - SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance
- Other Figures
-
- Figure 1
- Figure 1—figure supplement 1—source data 1.
- Figure 1—figure supplement 2.
- Figure 1—figure supplement 3.
- Figure 1—figure supplement 4.
- Figure 2
- Figure 2—figure supplement 1.
- Figure 2—figure supplement 2.
- Figure 2—figure supplement 3.
- Figure 3
- Figure 3—figure supplement 1.
- Figure 4—figure supplement 1.
- Figure 4—figure supplement 1.
- Figure 5.
- All Figure Page
- Back to All Figure Page
Figure 2—figure supplement 3.
(A) Western blot of SATB2 showing retained expression in long term in vitro cultures derived from MCR:SATB2 tumors. Actin loading control is shown. (B) Overall survival and (C) histology of irradiated Casper recipients transplanted with MCR:EGFP Zmel1 (n = 31) or MCR:SATB2 45–3 (n = 31) zebrafish long term in vitro cultures. (D) Weekly prospective imaging of primary MCR:SATB2 individual tumor donor allograft in irradiated Casper recipient. Arrows indicate distant metastasis from injection site. Related to Figure 2H. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife